drugset / Trial / NCT00546663
Tolerability of Inhaled Hypertonic Saline in Infants With Cystic Fibrosis
Completed
19 enrolled
CF Therapeutics Development Network Coordinating Center
Cystic Fibrosis Foundation · collab
NaSingle-groupOpen-labelTreatment
Summary
This is an open-label pilot study of the safety and tolerability of 7% hypertonic saline inhaled twice daily for 14 days in infants with CF, 12 to 30 months of age.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-05
- Completion
- 2008-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hypertonic saline | Unknown | 7 % | Inhaled |